AI Drug Developer METIS TECHBIO-P Continues to Attract Market Capital, Shares Surge Over 7% Before Noon
Deep News
Aug 10
Hot sector self-selected stocks, data centers, market trends, capital flows, and simulated trading clients are all focusing on METIS TECHBIO-P (07666). The stock continues to attract market capital, surging over 20% in early trading and leading the AI pharmaceutical sector. As of the time of writing, gains have narrowed slightly, with the stock price rising 7.19% to 11.92 Hong Kong dollars, and a turnover of 85.1 million Hong Kong dollars.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.